Search for other papers by Alessandro Ciresi in
Google Scholar
PubMed
Search for other papers by Stefano Radellini in
Google Scholar
PubMed
Search for other papers by Valentina Guarnotta in
Google Scholar
PubMed
Search for other papers by Maria Grazia Mineo in
Google Scholar
PubMed
Search for other papers by Carla Giordano in
Google Scholar
PubMed
and triglycerides. Low-density lipoprotein (LDL) cholesterol levels were evaluated by the following formula: total cholesterol–(HDL cholesterol–triglycerides/5). This sample also served as the baseline sample for an oral glucose tolerance test (OGTT
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Search for other papers by Bledar Daka in
Google Scholar
PubMed
Search for other papers by Thord Rosen in
Google Scholar
PubMed
Search for other papers by Per Anders Jansson in
Google Scholar
PubMed
Search for other papers by Lennart Råstam in
Google Scholar
PubMed
Department of Internal Medicine, Department of Clinical Sciences Malmö, Social Medicine and Global Health, University of Gothenburg, PO Box 454, SE-405 30 Gothenburg, Sweden
Search for other papers by Charlotte A Larsson in
Google Scholar
PubMed
Search for other papers by Ulf Lindblad in
Google Scholar
PubMed
−82 °C. In participants without known diabetes mellitus, an oral glucose tolerance test (OGTT) was performed to characterize the participants with impaired fasting glucose, impaired glucose tolerance, and diabetes mellitus according to WHO criteria
Search for other papers by Tao Yuan in
Google Scholar
PubMed
Search for other papers by Lanping Jiang in
Google Scholar
PubMed
Search for other papers by Chen Chen in
Google Scholar
PubMed
Search for other papers by Xiaoyan Peng in
Google Scholar
PubMed
Search for other papers by Min Nie in
Google Scholar
PubMed
Search for other papers by Xuemei Li in
Google Scholar
PubMed
Search for other papers by Xiaoping Xing in
Google Scholar
PubMed
Search for other papers by Xuewang Li in
Google Scholar
PubMed
Search for other papers by Limeng Chen in
Google Scholar
PubMed
then vertical for at least 2 h before the acquisition of blood samples. Plasma renin activity (PRA), angiotensin II (AngII) and aldosterone were detected by radioimmunoassay. Oral glucose tolerance test An oral glucose tolerance test (OGTT) was
Search for other papers by Agnieszka Adamska in
Google Scholar
PubMed
Search for other papers by Aleksandra Maria Polak in
Google Scholar
PubMed
Search for other papers by Anna Krentowska in
Google Scholar
PubMed
Search for other papers by Agnieszka Łebkowska in
Google Scholar
PubMed
Search for other papers by Justyna Hryniewicka in
Google Scholar
PubMed
Search for other papers by Monika Leśniewska in
Google Scholar
PubMed
Search for other papers by Irina Kowalska in
Google Scholar
PubMed
studies were performed during the early follicular phase (3–5 days) of their menstrual cycles. All subjects underwent an oral glucose tolerance test (OGTT) with 75 g of glucose. Anthropometric measurements BMI was calculated as body weight in
Search for other papers by Shilpa Lingaiah in
Google Scholar
PubMed
Search for other papers by Laure Morin-Papunen in
Google Scholar
PubMed
Search for other papers by Terhi Piltonen in
Google Scholar
PubMed
Search for other papers by Inger Sundström-Poromaa in
Google Scholar
PubMed
Search for other papers by Elisabet Stener-Victorin in
Google Scholar
PubMed
Department of Obstetrics and Gynaecology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
Search for other papers by Juha S Tapanainen in
Google Scholar
PubMed
tolerance test (OGTT) was carried out in 234 women with PCOS and in 109 non-PCOS controls. Fasting and two-hour glucose and insulin concentrations were measured after a 75 g glucose load. In the control group, 92.8% of the women had normal glucose tolerance
Surgery Research Unit, Cancer and Translational Medicine Research Unit, Medical Research Center Oulu, University of Oulu and Oulu University Hospital, Oulu, Finland
Search for other papers by Olli Helminen in
Google Scholar
PubMed
Search for other papers by Tytti Pokka in
Google Scholar
PubMed
Search for other papers by Susanna Aspholm in
Google Scholar
PubMed
Department of Pediatrics, University of Turku and Turku University Hospital, Turku, Finland
Search for other papers by Jorma Ilonen in
Google Scholar
PubMed
Search for other papers by Olli G Simell in
Google Scholar
PubMed
Pediatric Research Center, New Children’s Hospital, Helsinki University Hospital, Helsinki, Finland
Research Program for Clinical and Molecular Metabolism, Faculty of Medicine, University of Helsinki, Helsinki, Finland
Search for other papers by Mikael Knip in
Google Scholar
PubMed
Search for other papers by Riitta Veijola in
Google Scholar
PubMed
glucose tolerance test (OGTT) ( 9 ), random plasma glucose ( 9 ), C-peptide ( 10 ) and intravenous glucose tolerance test ( 11 ) can predict the timing of the diagnosis. For secondary prevention studies, the ability to predict the time and risk of the
Search for other papers by Jonathan Hazlehurst in
Google Scholar
PubMed
Search for other papers by Bernard Khoo in
Google Scholar
PubMed
Department of Medicine, Copenhagen University Hospital – Amager and Hvidovre, Hvidovre, Denmark
Search for other papers by Carolina Brito Lobato in
Google Scholar
PubMed
Search for other papers by Ibiyemi Ilesanmi in
Google Scholar
PubMed
Search for other papers by Sally Abbott in
Google Scholar
PubMed
Search for other papers by Tin Chan in
Google Scholar
PubMed
Search for other papers by Sanesh Pillai in
Google Scholar
PubMed
Search for other papers by Kate Maslin in
Google Scholar
PubMed
Imperial College Healthcare NHS Trust, St Mary’s Hospital, London, UK
Search for other papers by Sanjay Purkayastha in
Google Scholar
PubMed
Search for other papers by Barbara McGowan in
Google Scholar
PubMed
Search for other papers by Rob Andrews in
Google Scholar
PubMed
Search for other papers by Eveleigh Nicholson in
Google Scholar
PubMed
Search for other papers by Katherine McCullough in
Google Scholar
PubMed
Search for other papers by Lorraine Albon in
Google Scholar
PubMed
Search for other papers by Rachel Batterham in
Google Scholar
PubMed
Search for other papers by Georgios K Dimitriadis in
Google Scholar
PubMed
Search for other papers by Shareen Forbes in
Google Scholar
PubMed
Search for other papers by Gavin Bewick in
Google Scholar
PubMed
Search for other papers by Tricia M-M Tan in
Google Scholar
PubMed
phenomenon is possibly related to higher pre-operative β-cell function, insulin secretion and sensitivity ( 24 ). Indeed, the presence of pre-operative hypoglycaemia during an oral glucose tolerance test (OGTT) is associated with PBH ( 25 ). Other possible
Search for other papers by L Bahler in
Google Scholar
PubMed
Search for other papers by H J Verberne in
Google Scholar
PubMed
Search for other papers by E Brakema in
Google Scholar
PubMed
Search for other papers by R Tepaske in
Google Scholar
PubMed
Search for other papers by J Booij in
Google Scholar
PubMed
Search for other papers by J B Hoekstra in
Google Scholar
PubMed
Search for other papers by F Holleman in
Google Scholar
PubMed
measured, and a cannula was inserted into an antecubital vein to obtain blood samples during the oral glucose tolerance test (OGTT). Subjects were instructed to keep their diet as constant as possible during study participation. To check for possible
Search for other papers by Giorgio Bedogni in
Google Scholar
PubMed
Search for other papers by Andrea Mari in
Google Scholar
PubMed
Search for other papers by Alessandra De Col in
Google Scholar
PubMed
Search for other papers by Sofia Tamini in
Google Scholar
PubMed
Search for other papers by Amalia Gastaldelli in
Google Scholar
PubMed
Istituto Auxologico Italiano, IRCCS, Division of Metabolic Diseases and Auxology, Piancavallo (VB), Italy
Search for other papers by Alessandro Sartorio in
Google Scholar
PubMed
); (3) availability of oral glucose tolerance test (OGTT); (4) absence of type 1 or type 2 diabetes mellitus. The exclusion criteria were (1) genetic or syndromic obesity; (2) treatment with drugs known to interfere with glucose metabolism. The study was
Search for other papers by Angela Köninger in
Google Scholar
PubMed
Search for other papers by Antonella Iannaccone in
Google Scholar
PubMed
Search for other papers by Ensar Hajder in
Google Scholar
PubMed
Search for other papers by Mirjam Frank in
Google Scholar
PubMed
Search for other papers by Boerge Schmidt in
Google Scholar
PubMed
Search for other papers by Ekkehard Schleussner in
Google Scholar
PubMed
Search for other papers by Rainer Kimmig in
Google Scholar
PubMed
Search for other papers by Alexandra Gellhaus in
Google Scholar
PubMed
Search for other papers by Hans Dieplinger in
Google Scholar
PubMed
macrosomia and birth injury ( 17 , 18 ). Currently, determination of IR, for example with HOMA-IR, is not included in PCOS management guidelines. To exclude diabetes mellitus in PCOS patients, a 75 g oral glucose test (OGTT) is recommended in obese women